UK markets open in 6 hours 35 minutes
NIKKEI 225
38,978.01 +77.99 (+0.20%) HANG SENG
18,827.35 +218.41 (+1.17%) CRUDE OIL
78.75 +1.03 (+1.33%) GOLD FUTURES
2,354.00 +19.50 (+0.84%) DOW
39,069.59 +4.29 (+0.01%) Bitcoin GBP
54,262.11 +595.64 (+1.11%)
Enanta Pharmaceuticals, Inc. (9EP.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 09:55PM CEST
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 235.65M |
| Enterprise value | 1.36M |
| Trailing P/E | 424.30 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 3.41 |
| Price/book (mrq) | 1.50 |
| Enterprise value/revenue | 0.02 |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 0.54 |
| 52-week change 3 | -53.02% |
| S&P500 52-week change 3 | 26.14% |
| 52-week high 3 | 24.40 |
| 52-week low 3 | 7.50 |
| 50-day moving average 3 | 13.10 |
| 200-day moving average 3 | 11.10 |
Share statistics
| Avg vol (3-month) 3 | N/A |
| Avg vol (10-day) 3 | N/A |
| Shares outstanding 5 | 21.18M |
| Implied shares outstanding 6 | 21.62M |
| Float 8 | 15.4M |
| % held by insiders 1 | 6.09% |
| % held by institutions 1 | 107.15% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in USD.Fiscal year
| Fiscal year ends | 30 Sept 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -180.76% |
| Operating margin (ttm) | -192.13% |
Management effectiveness
| Return on assets (ttm) | -22.87% |
| Return on equity (ttm) | -60.50% |
Income statement
| Revenue (ttm) | 72.88M |
| Revenue per share (ttm) | 3.45 |
| Quarterly revenue growth (yoy) | -4.20% |
| Gross profit (ttm) | N/A |
| EBITDA | -132.81M |
| Net income avi to common (ttm) | -131.74M |
| Diluted EPS (ttm) | -5.78 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 300.31M |
| Total cash per share (mrq) | 14.18 |
| Total debt (mrq) | 229.86M |
| Total debt/equity (mrq) | 138.38% |
| Current ratio (mrq) | 6.43 |
| Book value per share (mrq) | 7.84 |
Cash flow statement
| Operating cash flow (ttm) | -107.32M |
| Levered free cash flow (ttm) | -67.16M |
© 2024 Yahoo. All rights reserved.